Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

aTYR PHARMA (ATYR) Operating Margin (2019 - 2025)

aTYR PHARMA (ATYR) has disclosed Operating Margin for 6 consecutive years, with 14076.32% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Operating Margin changed N/A year-over-year to 14076.32%, compared with a TTM value of 40856.32% through Dec 2025, down 1195674.0%, and an annual FY2025 reading of 40856.32%, down 1195674.0% over the prior year.
  • Operating Margin was 14076.32% for Q3 2025 at aTYR PHARMA, down from 7079.15% in the prior quarter.
  • Across five years, Operating Margin topped out at 76.55% in Q4 2022 and bottomed at 14076.32% in Q3 2025.
  • Average Operating Margin over 4 years is 6201.42%, with a median of 5326.4% recorded in 2024.